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Blimp1 (Prdm1), the key determinant of primordial
germ cells (PGCs), plays a combinatorial role with
Prdm14 during PGC specification from postimplan-
tation epiblast cells. They together initiate epigenetic
reprogramming in early germ cells toward an under-
lying pluripotent state, which is equivalent to embry-
onic stem cells (ESCs). Whereas Prdm14 alone
can promote reprogramming and is important for
the propagation of the pluripotent state, it is not
known whether Blimp1 is similarly involved. By using
a genetic approach, we demonstrate that Blimp1
is dispensable for the derivation and maintenance
of ESCs and postimplantation epiblast stem cells
(epiSCs). Notably, Blimp1 is also dispensable for
reprogramming epiSCs to ESCs. Thus, although
Blimp1 is obligatory for PGC specification, it is not
required for the reversion of epiSCs to ESCs and
for their maintenance thereafter. This study suggests
that reprogramming, including that of somatic cells
to ESCs, may not entail an obligatory route through
a Blimp1-positive PGC-like state.
INTRODUCTION
Expression of Blimp1, the key regulator of PGC specification, is
obligatory for the establishment of the germ cell lineage in mice
(Ohinata et al., 2005; Vincent et al., 2005). Blimp1 expression is
first detected in a few proximal postimplantation epiblast cells
at embryonic day (E) 6.25, which results in 30–40 founder
PGCs at E7.5 (Ohinata et al., 2005; Vincent et al., 2005). Blimp1
together with Prdm14 plays a critical role in early germ cells as
they induce repression of the somatic program, initiation of
PGC program-coupled epigenetic reprogramming, and re-
expression of pluripotency genes (Ohinata et al., 2005; Yamaji
et al., 2008). Thus, although PGCs are unipotent, they have an110 Cell Stem Cell 11, 110–117, July 6, 2012 ª2012 Elsevier Inc.epigenetic state and other properties, such as active X chromo-
somes in female PGCs, which resemble key features of the inner
cell mass (ICM) of blastocysts and ESCs. The reversion and re-
programming of postimplantation epiblasts and epiSCs to re-
verted ESC-like cells (henceforth called rESCs) is accompanied
by similar epigenetic changes to those seen during PGC specifi-
cation and early germ cells (Hajkova et al., 2008; Surani et al.,
2007; Bao et al., 2009).
Recent studies have shown that Prdm14 has a role in the
maintenance of mouse ESCs partly through the repression of
differentiation (Ma et al., 2011), and it is also obligatory for the
persistence of pluripotency in human ESCs (Chia et al., 2010).
Furthermore, Prdm14 enhances epigenetic reprogramming of
human and mouse somatic cells to induced pluripotent stem
cells (iPSCs) (Chia et al., 2010; Nagamatsu et al., 2011).
Prdm14 acts in conjunction with Blimp1 to induce epigenetic re-
programming in PGCs and early germ cells (Yamaji et al., 2008),
suggesting that they play a combinatorial role in the germ cell
lineage. This, together with other observations, has led to
a notion that reprogramming in other contexts, including that
of somatic cells to a ground state of pluripotency seen in
ESCs, might entail a transition through a PGC-like state (Zwaka
and Thomson, 2005; Nichols and Smith, 2011; Nagamatsu et al.,
2011; Chu et al., 2011).
EpiSCs, which are derived from postimplantation epiblast
cells, inherit some of the key properties from them, including
an inactive X chromosome in female cells, which differ in many
other respects too, including their epigenetic state compared
to the ESCs derived from the ICM of blastocysts (Tesar et al.,
2007; Brons et al., 2007). Furthermore, epiSCs gain additional
DNA methylation at some loci, such as stella (Dppa3) and
Rex1, during their derivation from epiblast cells (Bao et al.,
2009). We showed previously that some epiSCs can undergo
PGC specification after expression of Blimp1 and Prdm14
accompanied by appropriate epigenetic reprogramming,
consistent with observations on PGCs in vivo (Hayashi and Sur-
ani, 2009). Furthermore, the reversion of epiSCs to rESCs in
response to leukaemia inhibitory factor (LIF)-Stat3 is similarly
accompanied by epigenetic reprogramming, X reactivation, re-
expression of pluripotency genes, DNA demethylation, and
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Figure 1. Derivation ofBlimp1–/– ESCs from
Blastocysts
(A) Summary of Blimp1/ ESC derivations from
whole ICMs.
(B) Summary of ESC derivations from trypsinized
ICMs plated as single cells.
(C) Oct4 and Nanog immunostaining of
Blimp1/, Blimp1+/, and Blimp1+/+ ESCs.
(D) Chimeras generated with Blimp1/ ESCs
(dark agouti) injected into albino C57BL/6 blas-
tocysts.
See also Tables S1 and S2.
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Blimp1 Is Dispensable for Pluripotencyrepression of somatic genes (Bao et al., 2009; Hanna et al., 2009;
Yang et al., 2010; Greber et al., 2010). Thus, there are some key
shared features of epigenetic reprogramming of epiSCs during
PGC specification and during reversion to rESCs.
We previously excluded a possibility that rESCs may be
derived from dedifferentiating PGCs (Bao et al., 2009). However,
further evidence is required to exclude this likelihood unequivo-
cally, and particularly also a possibility that the reversion of
epiSCs to rESCs could involve a transition through a PGC-like
state, especially as they share some key features of epigenetic
reprogramming. If so, we would anticipate a key role for Blimp1
during the reversion of epiSCs to rESCs and possibly in other
instances of reprogramming of somatic cells to iPSCs in vitro.
Note that Blimp1 is at the same time also essential for differenti-
ation of some somatic cells later during embryogenesis (Robert-
son et al., 2007).
In this study we investigated whether Blimp1 is required for the
generation and maintenance of the ESC state. Our study shows
that whereas Blimp1 is obligatory for PGC specification, it is
dispensable during the derivation of ESCs and epiSCs, as well
as during the reversion of epiSCs to ESCs and their long-term
maintenance thereafter as self-renewing pluripotent stem cells.
Blimp1/ ESCs are also capable of differentiating into somatic
cells in chimeras, and development as early postimplantation
embryos in tetraploid rescue experiments, but they cannot give
rise to the germ cell lineage.
RESULTS AND DISCUSSION
Assessment of the Requirement of Blimp1 for ESC
Derivation
First, we set out to test whether Blimp1 is essential for the
establishment of ESCs. To do so, we intercrossed mice hetero-
zygous for a Blimp1 mutant allele (Ohinata et al., 2005) and
retrieved 8-cell stage embryos. These embryos were cultured
in medium supplemented with the small molecules PD0325901
and Chir99021 (2i) to inhibit the protein kinase (Erk1/2) cascadeCell Stem Cell 11, 110–and glycogen synthase kinase, respec-
tively (Nichols et al., 2009; Ying et al.,
2008). After 3 days, all embryos formed
expanded blastocysts and hatched
from the zona pellucida. The ICMs were
isolated from expanded blastocysts by
immunosurgery and transferred to 2i
medium supplemented with LIF. Theouter trophectoderm cells from individual embryoswere retained
and used to genotype the respective epiblast. We found 8/40
embryos to be null for Blimp1 by trophectoderm genotyping (Fig-
ure 1A). These epiblasts were allowed to grow for a further 4 days
and primary colonies were expanded as ESC lines. Lines were
established from 7/8 embryos and each line was regenotyped,
which confirmed that 6/7 ESC lines were null for Blimp1 (Fig-
ure 1A). In a separate experiment, an ESC line was established
from each of 10 embryos, and one of these was shown to be
null for Blimp1 (Table S1 available online). These experiments
show that it is possible to derive ESC lines directly from
Blimp1/ blastocysts. Note that the 2i conditions are not essen-
tial for the establishment of ESCs as shown by the fact that rever-
sion of epiSCs to rESCs occurred efficiently under classical
culture conditions with LIF and fetal calf serum (see later).
To test whether the Blimp1-null ESCs are in any way compro-
mised, we tested their colony-forming ability at the single cell
level. In this case, we obtained 11 embryos at E4.5 by crossing
Blimp1+/ heterozygous mice and repeated the procedure for
ESC derivation described above, except that the ICM from
each embryo was dissociated into single cells and then
dispersed onto a feeder layer in a 48-well culture dish. The colo-
nies in each of the wells were counted after 5 days. Two
embryos, which had small ICMs, produced no colonies. Cells
from the remaining 9 ICMs produced between 1 and 11 colonies
(Figure 1B), consistent with previous findings (Nichols et al.,
2009). Individual colonies were picked and multiple ESC lines
were established from each embryo, with the exception of
embryo 10, which produced only one primary colony. Each
ESC line was genotyped for Blimp1 and in every case lines
derived from the same embryo were of the same genotype
(data not shown). For example, all 4 ESC lines from embryo 5,
which produced 11 primary colonies, were Blimp1 null (Fig-
ure 1B), which is comparable with the maximum efficiency re-
ported previously (Nichols et al., 2009). This demonstrates that
the derivation of ESCs from Blimp1 mutant embryos occurs
efficiently and is not detectably compromised. Indeed, from 3117, July 6, 2012 ª2012 Elsevier Inc. 111
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Figure 2. Reprogramming of Blimp1–/– EpiSCs to rESCs and Expression Analysis of Blimp1-null Pluripotent Stem Cell Lines
(A) Embryo at E6.5 generated from Blimp1/ ESCs after injection into 4N teraploid host blastocyst. Epiblast tissue was divested of the proximal region (black
line). epi, epiblast; exe, extraembryonic ectoderm; epc, ectoplacental cone.
(B) Dissected epiblast tissue.
(C) Derivation of epiSCs from epiblast.
(D) AP staining in epiSCs.
(E) Derivation of rESCs from epiSCs.
(F) Uniform AP staining of rESCs.
Scale bars represent 200 mm.
(G and H) Number of Blimp1/ rESCs from Blimp1/ epiSCs of 129 inbred genetic background (G) and mixed genetic background (H).
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Blimp1 Is Dispensable for Pluripotencyindependent ESC derivation experiments, we have obtained
a total of 11 separate Blimp1-null ESC lines from 9 Blimp1-null
blastocysts. Blimp1-null ESCs, as well as control heterozygous
and wild-type lines, were immunoreactive for the key pluripo-
tency transcription factors Oct4 and Nanog (Figure 1C).
Next, we carried out a functional test on Blimp1/ ESCs by
examining whether they can participate in forming chimeric adult
mice by injecting them into wild-type host blastocysts. We
observed extensive contribution of Blimp1/ ESCs as judged
by their contribution to coat color. However, as expected, we
did not observe germline transmission in the absence of Blimp1
(Figure 1D; Table S2). We had similar results with rESCs (see
later). We conclude that pluripotent ESCs can be established
efficiently from embryos with homozygous genetic deletion of
Blimp1. We do not rule out that ESC derivation by alternative
strategies or from particular mouse strains may require Blimp1
activity. The ESC lines established here were of a mixed,
predominantly C57BL/6 and CBA, genetic background;
Blimp1-null ESCs of the permissive 129 homozygous genetic
background are phenotypically similar to that of the mixed
genetic background (data not shown). All these ESC lines are
indistinguishable from wild-type ESCs in culture. We have main-
tained Blimp1/ ESCs for more than 30 passages both in 2i/LIF
conditions as well as in conventional cultures with fetal calf
serum (FCS) and LIF (with or without feeders) for more than
15 passages without detectable effects on the properties of
these ESCs.
Derivation of EpiSCs from Blimp1–/– Postimplantation
Epiblast Cells
We next asked whether it is possible to derive epiSC lines from
Blimp1/ postimplantation epiblast cells. For this purpose, we
used established Blimp1/ ESC lines (129 background) and in-
jected them into wild-type tetraploid host blastocysts, which
contribute almost exclusively to extraembryonic tissues,
including the visceral endoderm, while the donor ESCs
contribute to the embryo proper (Nagy et al., 2003).
Twelve embryos were isolated at E6.5 for the derivation of
epiSCs (Figure 2A). The epiblast tissue was dissected to remove
the most proximal region and the outer visceral endoderm (Fig-
ure 2B). The resulting cells were cultured in Activin A and bFGF
in a chemically defined serum replacement medium (henceforth
called CDM) on mouse embryonic fibroblasts feeders (MEFs) as
described previously (Bao et al., 2009). After 4–7 days, we de-
tected large colonies in 10/12 cultures with many alkaline phos-
phatase (AP)-positive cells (Figures 2C and 2D). We propagated
these epiSC colonies in CDM by collagenase treatment without
detectable morphological changes for at least 20 passages.
Notably, we obtained similar epiSC lines both from the inbred
129 and mixed genetic background. Both wild-type and
Blimp1-null epiSCs showed a similar morphology and could be
maintained in culture thereafter (Figures 2G and 2H).(I) qRT-PCR analysis of Blimp1/ epiSCs, ESCs, and rESCs. rESCs and ESC
fibroblasts (MEFs) were used as control. At least two, and usually three, biological
standard deviation of two technical replicates.
(J) Correlation heatmap generated after microarray analysis of the cell lines analy
included. Asterisk denotes rESC lines.
See also Figure S1 and Table S3.Investigation of the Requirement of Blimp1 for
Reversion of EpiSCs to rESCs
After establishment of 10 Blimp1/ epiSC lines, we tested their
ability to undergo reversion to rESCs by transferring them to
medium containing LIF and FCS as described previously (Bao
et al., 2009). After 12–30 days in culture, we started to detect
clusters of cells with a different morphology from the original
epiSCs. Subsequent culture of these cells was carried out after
disruption of the developing colonies by treatment with trypsin,
which is detrimental to the remaining epiSCs but promotes prop-
agation of ESC-like cells. With further passaging, we established
multiple Blimp1-null rESC lines (4/10) (Figures 2E and 2F). We
also derived Blimp1/ epiSCs from Blimp1+/ heterozygous
intercrosses (Figures S1A and S1B). These too readily reverted
to give rESC lines, and notably the dynamics of reprogramming
was indistinguishable when compared with reversion of epiSCs
derived from Blimp1 heterozygous littermate (Figure S1C).
Next we analyzed the gene expression profile of Blimp1/
ESCs, epiSCs, rESCs, and heterozygous control lines by quanti-
tative RT-PCR (qRT-PCR). All lines expressed the pluripotency
factors Oct4 and Nanog (Figure 2I). EpiSC lines expressed low
levels of Klf2 and Klf4 and high levels of Fgf5 and Foxa2 (Fig-
ure 2I). In contrast, rESCs displayed a gene expression pattern
indistinguishable from ESCs, indicating successful reprogram-
ming. There was no obvious effect of loss of Blimp1 on the
gene expression profile of epiSCs, ESCs, or rESCs (Figure 2I).
Female Blimp1-null epiSCs also exhibited nuclear H3K27me3
foci, which is lost upon reversion to rESCs, consistent with the
reactivation of the inactive X chromosome that occurs as effi-
ciently in the absence of Blimp1 (Figure S1D).
Next we investigated the transcriptome of Blimp1-null plurip-
otent stem cells by microarray analysis. The rESC and ESC lines
clustered together, indicating successful transcriptional reprog-
ramming during the reversion process and were clearly distinct
from epiSCs (Figure 2J). Direct comparison between rESC and
epiSC lines showed 3,868 differentially expressed genes (false
discovery rate [FDR] adjusted p value < 0.01). ESCs cultured in
2i/LIF also formed a discrete cluster, suggesting a broad tran-
scriptional change in this condition, consistent with observations
in our laboratory (H.G.L. and M.A.S., unpublished observations).
However, there was no detectable effect on cells with a loss of
Blimp1 in any of the cell types we tested. Pairwise comparisons
between epiSCs showed a correlation of >0.96 between cells
with and without Blimp1, with fewer than 400 genes differentially
expressed in any single comparison (Figure S1E). Such small
variations are routinely evident even between heterozygous
epiSC lines, which are consistent with published data for wild-
type epiSCs (Figure S1E; Han et al., 2011). Furthermore,
comparisons between Blimp1-null ESCs (or rESCs) and control
lines revealed no differentially expressed genes, in either stan-
dard or 2i/LIF culture conditions (FDR adjusted p value < 0.01
for each comparison). These results indicate that Blimp1-nulls were cultured in FCS/LIF. Heterozygous cell lines and mouse embryonic
replicates were analyzed for each cell type and genotype. Error bars denote the
zed in (I). The same Blimp1/ and Blimp1+/ ESCs cultured in 2i/LIF were also
Cell Stem Cell 11, 110–117, July 6, 2012 ª2012 Elsevier Inc. 113
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Figure 3. PGCs in Embryos Generated from
Blimp1–/– rESCs and control rESCs
(A) Chimeras generated with Blimp1/ rESCs (dark
agouti) injected into C57BL/6 (black) blastocysts.
(B) Summary of blastocyst injections.
(C and D) Comparison of PGCs detected by AP staining at
E8.5 in WT control (C) embryos, versus Blimp1/ (D)
embryos, revealed migrating PGCs in wild-type embryos
(arrowheads) and only a few nonmigrating AP-positive
cells in Blimp1/ embryos. al, allantois. Scale bar
represents 200 mm.
(E) Number of PGCs detected in control E8.5 embryos
(n = 6) and Blimp1/ E8.5 embryos (n = 8) of 129 genetic
background Blimp1/ rESCs.
(F) PGCs from control E8.5 embryos (n = 17) and mutant
rESC-derived E8.5 embryos (n = 12) of mixed genetic
background.
See also Figure S2.
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tical with normal ESCs, notwithstanding their inability to
contribute to the germline and some somatic tissues later in
embryogenesis.
Blimp1-null rESCs, like Blimp1-null ESCs, can contribute to
chimeras (Figures 3A and 3B), which provides functional proof
for complete reversion in the absence of Blimp1. Next we
checked whether Blimp1/ rESCs contribute to the entire
developing embryo by using the ‘‘tetraploid rescue’’ experi-
mental approach (Nagy et al., 2003). We obtained comparable
E8.5 embryos from both normal and Blimp1/ rESCs (Figures
S2A and S2B), indicating their potential for extensive differentia-
tion. Note that Blimp1 is important later for development of some
somatic cells and this will influence differentiation of Blimp1/
cells in some tissues in chimeras (Robertson et al., 2007), which
is in contrast to its role under consideration in this investigation
concerning pluripotency and reprogramming.
Next we examined the E8.5 embryos generated from ESCs in
tetraploid rescue experiments for the presence of PGC-like cells
by staining for AP (Lawson et al., 1999). We found a striking
difference in embryos generated from Blimp1/ rESCs in which114 Cell Stem Cell 11, 110–117, July 6, 2012 ª2012 Elsevier Inc.we saw no AP-positive cluster at the base of the
allantois (6/8), except for fewer than 6 AP-posi-
tive cells near the base of the allantois in 2
embryos, which did not seem to be migrating
appropriately like authentic PGCs (Figures 3D
and 3E). By contrast, we observed normal clus-
ters of PGCs in control embryos (Figure 3C). We
previously demonstrated that AP-positive cells
in Blimp1 mutant embryos lack all the attributes
of authentic PGCs; instead, they have some
characteristics of neighboring somatic cells
with the expression of certain Hox genes,
absence of PGC markers, and lack of expres-
sion of key pluripotency genes such as Sox2,
and they undergo apoptosis after a lack of
proliferation (Ohinata et al., 2005). Similar
results were obtained with an independently
derived Blimp1/ rESC line of mixed genetic
background (Figure 3F). These findings mirrorthe phenotype of similar AP-positive aberrant cells observed in
Blimp1/ embryos, obtained by heterozygous crosses, at the
same stage.
These results show that loss of Blimp1 does not prevent deri-
vation of epiSCs or their reversion to rESCs. The combined data
also show that Blimp1/ rESCs are similar to control rESCs by
transcriptome analysis as they both contribute to adult chimeras,
except that the mutant cells cannot undergo specification into
PGCs and be transmitted through the germline; they may also
not contribute to some somatic tissues where Blimp1 is required
later in development as shown previously (Robertson et al.,
2007). Because rESCs can be derived from Blimp1-null epiSCs,
this provides evidence indicating that epigenetic reprogramming
inherent to the reversion process does not involve obligatory
dedifferentiation of PGCs, and importantly, unequivocally
excludes an obligatory transition through Blimp1-positive
PGC-like state.
Conclusion
Blimp1 is obligatory for PGC specification but it does not appear
to be required for the derivation or the maintenance of
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blastocyst
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E6.5 epiblast Blimp1 -/-
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Figure 4. Representation of Blimp1 Requirement in Pluripotency,
Reprogramming, and Germ Cells
Blimp1 is not essential for the derivation and the maintenance of pluripotent
ESCs or epiSCs. Reprogramming of epiSCs to rESCs, which is accompanied
by epigenetic changes such as DNA demethylation and X reactivation that are
also detected in the early germline, can also occur in the absence of Blimp1. By
contrast, Blimp1 is critical for PGC specification and epigenetic reprogram-
ming in early germ cells, which is mechanistically unrelated to the re-
programming of epiSCs to rESCs that does not entail an obligatory route
through a PGC-like state.
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Blimp1 Is Dispensable for Pluripotencypluripotent ESCs or ofBlimp1/ epiSCs. Importantly,Blimp1/
epiSCs can undergo appropriate epigenetic reprogramming and
reversion to rESCs in response to LIF-STAT3 signaling. This is
a very stringent test for whether or not Blimp1 is essential, since
reversion entails X reactivation and DNA demethylation; this
occurred in the presence of LIF-serum and did not require 2i
culture conditions. Reprogramming of Blimp1-null epiSCs to
Blimp1/ rESCs conclusively excludes their transition through
a Blimp1-positive PGC-like state. Because PGC specification
and establishment of the germline is impossible without Blimp1,
it is reasonable to conclude that reversion of epiSCs to rESCs
does not transit through an equivalent PGC-like state.
Blimp1 and Prdm14 together are critical for epigenetic reprog-
ramming during specification of PGCs and early germ cells. Re-
programming in early germ cells shares some key features with
the reversion of epiSCs to rESCs. However, our study shows
that reprogramming of epiSCs to rESCs, and possibly of somatic
cells to iPSCs, does not require Blimp1, although PRDM14
appears to be essential for the maintenance of human and
potentially mouse ESCs but not the mouse epiSCs (Chia et al.,
2010; A.G. and M.A.S., unpublished observation). By contrast,
Blimp1 is not required for the derivation and maintenance of
mouse ESCs or epiSCs. Indeed, Blimp1 is rapidly downregu-
lated during reprogramming of normal PGCs to pluripotentembryonic germ cells (EGCs), suggesting that Blimp1 is critical
for the maintenance of unipotent germ cells, but it may restrict
reversion to a pluripotent state because EGCs are equivalent
to ESCs (Durcova-Hills et al., 2008; Leitch et al., 2010). Thus,
PGC specification from epiblasts and epiSCs on the one hand
and reversion of epiSCs to rESCs on the other (Figure 4) serves
as a good model to gain novel insights on diverse mechanisms
underlying epigenetic reprogramming in different contexts.
EXPERIMENTAL PROCEDURES
Embryos
Timed natural matings were used for all experiments, where noon of the day
when the vaginal plugs of mated females were identified was scored as
E0.5. MEFs were obtained from E13.5 fetuses from the MF1 strain. Animal
studies were authorized by a UK Home Office Project License and carried
out in a Home Office-designated facility.
Derivation of Mouse ESCs from Blimp1–/– Blastocysts
ESC lines were derived essentially as described previously (Nichols et al.,
2009). For single-cell deposition experiments, single-cell suspensions from
each trypsinized ICM were dispersed in one well of a 48-well plate containing
HS-27 feeders (available from ATCC). 2i/LIF medium comprises N2B27 basal
medium (Stem Cells Inc.) supplemented with 1 mM PD0325901, 3 mM
CHIR99021 (Signaling Technologies, University of Dundee), and mouse LIF
(10 mg/ml, University of Cambridge Department of Biochemistry).
Production of E6.5 Epiblast in Tetraploid Host Blastocysts
Two-cell stage embryos (E1.5) from F1 (C57BL/6 3 CBA) matings were
collected by flushing oviducts; these were subjected to electrofusion to create
tetraploid (4N) host blastocysts (Nagy et al., 2003). Typically 15–20 Blimp1/
ESCs were injected into tetraploid host blastocyts, which were transferred to
E2.5 pseudopregnant recipients, and examined at E6.5.
Blimp1–/– EpiSC Derivation and Culture
EpiSCs were derived from E6.5 epiblasts by culturing on MEFs in N2B27
medium containing human activin A (20 ng/ml; Peprotech), bFGF (12 ng/ml;
Invitrogen), and KSR (20%; Invitrogen) (Bao et al., 2009). The cells were
passaged every 3 days as described previously. When the colonies increased
in size, they were dissociated with collagenase IV (1mg/ml; Invitrogen) until the
establishment of epiSCs after about 10 passages.
Reversion of Mouse Blimp1–/– EpiSC to rESC Lines
Blimp1/ epiSCs (passage 20) were treated with collagenase for 8 min at
room temperature and transferred to a dish with feeders and standard ESC
medium (1,000 U/ml LIF, 20% FCS in DMEM/F12 medium). After 12 to
30 days, colonies of 100 to 200 mm diameter were detected, within which
we detected clusters of cells with a different morphology. These cultures
were dissociated by trypsin into single-cell suspension and passaged on
feeders and standard ESC medium. ESC-like cell were detected several
days later and established as mutant or control rESCs.
Alkaline Phosphatase Staining
AP staining of epiSCs and rESCs was carried out according to manufacturer’s
instructions (Roche). In brief, the cells were fixed in 4% paraformaldehyde for
10 min and stained overnight at room temperature. AP staining of PGCs was
performed as described previously (Lawson et al., 1999).
Quantitative Real-Time PCR
Total RNA was extracted with the RNeasy Mini Kit (QIAGEN) with DNase treat-
ment. 500 ng of total RNA were used for cDNA synthesis with Superscript III
(Invitrogen) and random hexamer primers (Invitrogen). qRT-PCR reactions
were set up with Sybr Green JumpStart Taq ReadyMix (Sigma) and 1 mM of
forward and reverse gene-specific primers (see Table S3 for primer
sequences). Amplification was performed with an ABI Prism 7000 Sequence
Detection System (Applied Biosystems) at 95C for 10 min, 40 cycles ofCell Stem Cell 11, 110–117, July 6, 2012 ª2012 Elsevier Inc. 115
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cycles were determined from two technical replicates by the comparative Ct
method and expression levels were normalized to GAPDH.
Microarray Analysis
Total RNA was prepared with the RNeasy Mini Kit (QIAGEN) with DNaseI treat-
ment. Eluted RNA concentration was determined by spectrophotometry. After
RNA quality control with the Bioanalyzer, the samples were processed and
hybridized to IlluminaMouseWG-6 v2.0 Expression BeadChips by Cambridge
Genomic Services, who also performed data quality control. Raw data were
loaded into lumi (Du et al., 2008) and then divided into subsets to be analyzed.
The data were transformed by variance stabilization (VST) (Lin et al., 2008) and
normalized with quantile normalization. Comparisons were performed by
limma (Smyth, 2004) and the results corrected by false discovery rate (FDR).
Microarray data are presented as a correlation heatmap that depicts the corre-
lation between samples.
Immunostaining
Cells were briefly washed with PBS and fixed in 4% paraformaldehyde in PBS
for 15 min at room temperature. Cells were permeabilized for 30 min with 1%
BSA and 0.1% Triton X-100 in PBS. Antibody staining was carried out in the
same buffer at 4C overnight. The slides were subsequently washed three
times in PBS, 1% BSA, and 0.1% Triton X-100 (5 min each wash), incubated
with secondary antibody for 1 hr at room temperature in the dark, and washed
once for 5 min in PBS, 1% BSA, and 0.1% Triton X-100 and twice for 5 min in
PBS. The slides were then mounted in Vectashield with DAPI (Vector Labora-
tories) and imaged with a BioRad Radiance 2100 confocal microscope.
Primary antibodies used were mouse monoclonal Oct4 (BD Biosciences,
1:200), rabbit polyclonal Nanog (Abcam, 1:200). All secondary antibodies
used were Alexa Fluor highly crossed adsorbed (Molecular Probes).
Detection of PGC-like Cells
We injected Blimp1/ rESCs derived from Blimp1/ epiSCs into tetraploid
host blastocysts and transferred them to E2.5 recipients. E8.5 embryos
were isolated and PGC-like cells were counted after AP staining. The reprog-
rammed rESCs derived from epiSCs with Oct4-DPE-GFP reporter were used
as a control.
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE35983.
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